Condition: Myelodysplastic Syndromes · Sponsor: Takeda
The main aim of the study is to evaluate how TAK-226 improves symptoms of transfusion-dependent anemia in Japanese patients with lower-risk myelodysplastic syndromes. The study consists of Screening Period (up to 6 weeks), Treatment Period, Safety Follow-Up Period (8 weeks), and Long-Term Follow-Up Period (5 years from the first dose of the study drug or 3 years after the last dose, whichever is longer). Participants of this study will be administered TAK-226 during Treatment Period. Subsequently, the participants will be monitored for side effects related to the study treatment during Safety Follow-Up Period and Long-Term Follow-Up Period. The approximate duration of participation for a participant is up to approximately 6 years. During the study period, participants will visit the study clinic/hospital multiple times as per the study schedule. During Treatment Period, the participants will come to the clinic/hospital approximately every two to four weeks.
This description comes directly from the study's public registry record.
Takeda Contact · +1-877-825-3327 · medinfoUS@takeda.com
Always discuss trial participation with your own doctor first.
| Tokyo Metropolitan Komagome Hospital | Tokyo, Bunkyo-ku, Japan | Not Yet Recruiting |
| University of Fukui Hospital | Fukui, Eiheiji, Japan | Not Yet Recruiting |
| Japan Mutual Aid Association of Public School Teachers Chugoku Central Hospital | Hiroshima, Fukuyama, Japan | Not Yet Recruiting |
| Tokai University Hospital | Kanagawa, Isehara, Japan | Not Yet Recruiting |
| JCHO Kyushu Hospital | Fukuoka, Kitakyushu, Japan | Not Yet Recruiting |
| Kobe City Hospital Organization Kobe City Medical Center General Hospital | Hyōgo, Kobe, Japan | Not Yet Recruiting |
| Yamanashi Prefectural Central Hospital | Yamanashi, Kofu, Japan | Not Yet Recruiting |
| Matsuyama Red Cross Hospital | Ehime, Matsuyama, Japan | Not Yet Recruiting |
| Dokkyo Medical University Hospital | Tochigi, Mibu, Japan | Not Yet Recruiting |
| National Hospital Organization Nagoya Medical Center | Aichi, Nagoya, Japan | Not Yet Recruiting |
| Japanese Red Cross Narita Hospital | Chiba, Narita, Japan | Not Yet Recruiting |
| Kitasato University Hospital | Kanagawa, Sagamihara, Japan | Not Yet Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07319845